Binding of PAT-SM6 to the surface of MM cells results in the induction of apoptosis and CDC, but not ADCC, demonstrating that a fully human IgM antibody can specifically target and eliminate malignant plasma cells. Here, CD40LG is linked to Miyoshi myopathy.